Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
EL-Habib Dakir, Adam Pickard, Kirtiman Srivastava, Cian M. McCrudden, Stephane R. Gross, Stephen Lloyd, Shu-Dong Zhang, Andriana Margariti, Richard Morgan, Philip S. Rudland, Mohamed El-Tanani
Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34889-34910
Dennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, Carmen Behrens, Neda Kalhor, Huiqin Chen, Li Shen, J. Jack Lee, Waun Ki Hong, Ximing Tang, Luc Girard, John D. Minna, Lixia Diao, Jing Wang, Barbara Mino, Pamela Villalobos, Jaime Rodriguez-Canales, Nana E. Hanson, James Sun, Vincent Miller, Joel Greenbowe, Garrett Frampton, Roy S. Herbst, Veera Baladandayuthapani, Ignacio I. Wistuba, Julie G. Izzo
Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33995-34008
Shahid Shah, Caroline Fourgeaud, Simon Derieux, Shahsoltan Mirshahi, Geneviève Contant, Cynthia Pimpie, Rea Lo Dico, Jeannette Soria, Marc Pocard, Massoud Mirshahi
Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33778-33787